{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:55:02Z","timestamp":1789779302486,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["RS-2023-00273406"],"award-info":[{"award-number":["RS-2023-00273406"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-024-01475-3","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:14:48Z","timestamp":1738282488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of denosumab and zoledronic acid on postmenopausal osteoporosis, bone density, and fat-free mass"],"prefix":"10.1007","volume":"20","author":[{"given":"Jeonghoon","family":"Ha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaiho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejee","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Hyun","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Catholic Medical Center Bone Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"1475_CR1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1056\/NEJM199803123381107","volume":"338","author":"R Eastell","year":"1998","unstructured":"Eastell R (1998) Treatment of postmenopausal osteoporosis. N Engl J Med 338:736\u2013746","journal-title":"N Engl J Med"},{"key":"1475_CR2","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(02)08827-X","volume":"359","author":"PD Delmas","year":"2002","unstructured":"Delmas PD (2002) Treatment of postmenopausal osteoporosis. Lancet 359:2018\u20132026","journal-title":"Lancet"},{"key":"1475_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.maturitas.2011.01.014","volume":"68","author":"V Messier","year":"2011","unstructured":"Messier V, Rabasa-Lhoret R, Barbat-Artigas S, Elisha B, Karelis AD, Aubertin-Leheudre M (2011) Menopause and sarcopenia: a potential role for sex hormones. Maturitas 68:331\u2013336","journal-title":"Maturitas"},{"key":"1475_CR4","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab 104:1595\u20131622","journal-title":"J Clin Endocrinol Metab"},{"key":"1475_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N et al (2020) American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 26:1\u201346","journal-title":"Endocr Pract"},{"key":"1475_CR6","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1111\/jgs.16165","volume":"67","author":"S Phu","year":"2019","unstructured":"Phu S, Bani Hassan E, Vogrin S, Kirk B, Duque G (2019) Effect of denosumab on falls, muscle strength, and function in community-dwelling older adults. J Am Geriatr Soc 67:2660\u20132661","journal-title":"J Am Geriatr Soc"},{"key":"1475_CR7","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1172\/JCI125915","volume":"129","author":"N Bonnet","year":"2019","unstructured":"Bonnet N, Bourgoin L, Biver E, Douni E, Ferrari S (2019) RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest 129:3214\u20133223","journal-title":"J Clin Invest"},{"key":"1475_CR8","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/jbmr.4417","volume":"36","author":"SE Noel","year":"2021","unstructured":"Noel SE, Santos MP, Wright NC (2021) Racial and ethnic disparities in bone health and outcomes in the United States. J Bone Miner Res 36:1881\u20131905","journal-title":"J Bone Miner Res"},{"key":"1475_CR9","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/ajcn\/41.4.810","volume":"41","author":"HC Lukaski","year":"1985","unstructured":"Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI (1985) Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41:810\u2013817","journal-title":"Am J Clin Nutr"},{"key":"1475_CR10","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.clnu.2004.06.004","volume":"23","author":"UG Kyle","year":"2004","unstructured":"Kyle UG, Bosaeus I, De Lorenzo AD et al (2004) Bioelectrical impedance analysis\u2013part I: review of principles and methods. Clin Nutr 23:1226\u20131243","journal-title":"Clin Nutr"},{"key":"1475_CR11","doi-asserted-by":"crossref","unstructured":"Janssen I, Heymsfield SB, Baumgartner RN (2000) Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 89:465\u2013471","DOI":"10.1152\/jappl.2000.89.2.465"},{"key":"1475_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/oby.20583","volume":"22","author":"E Sillanp\u00e4\u00e4","year":"2014","unstructured":"Sillanp\u00e4\u00e4 E, Cheng S, H\u00e4kkinen K, Finni T, Walker S, Pesola A, Ahtiainen J, Stenroth L, Sel\u00e4nne H, Sipil\u00e4 S (2014) Body composition in 18- to 88-year-old adults\u2013comparison of multifrequency bioimpedance and dual-energy X-ray absorptiometry. Obesity 22:101\u2013109","journal-title":"Obesity"},{"key":"1475_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/M22-1034","volume":"176","author":"A Qaseem","year":"2023","unstructured":"Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I et al (2023) Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians. Ann Intern Med 176:224\u2013238","journal-title":"Ann Intern Med"},{"key":"1475_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.11005\/jbm.2023.30.4.289","volume":"30","author":"SY Park","year":"2023","unstructured":"Park SY, Kim SH, Lee YK, Shin JH, Ha YC, Chung HY (2023) Position statement: postmenopausal osteoporosis treatment strategies in Korea. J Bone Metab 30:289\u2013295","journal-title":"J Bone Metab"},{"key":"1475_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","volume":"17","author":"CL Gregson","year":"2022","unstructured":"Gregson CL, Armstrong DJ, Bowden J et al (2022) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 17:58","journal-title":"Arch Osteoporos"},{"issue":"Suppl 1","key":"1475_CR16","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jfma.2023.01.007","volume":"122","author":"TW Tai","year":"2023","unstructured":"Tai TW, Huang CF, Huang HK et al (2023) Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update. J Formos Med Assoc 122(Suppl 1):S4-s13","journal-title":"J Formos Med Assoc"},{"key":"1475_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nrendo.2015.71","volume":"11","author":"IR Reid","year":"2015","unstructured":"Reid IR (2015) Short-term and long-term effects of osteoporosis therapies. Nat Rev Endocrinol 11:418\u2013428","journal-title":"Nat Rev Endocrinol"},{"key":"1475_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12325-021-01936-y","volume":"39","author":"DL Kendler","year":"2022","unstructured":"Kendler DL, Cosman F, Stad RK, Ferrari S (2022) Denosumab in the treatment of osteoporosis: 10 years later: a narrative review. Adv Ther 39:58\u201374","journal-title":"Adv Ther"},{"key":"1475_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","volume":"5","author":"HG Bone","year":"2017","unstructured":"Bone HG, Wagman RB, Brandi ML et al (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5:513\u2013523","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1475_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jbmr.1494","volume":"27","author":"DM Black","year":"2012","unstructured":"Black DM, Reid IR, Boonen S et al (2012) The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res 27:243\u2013254","journal-title":"J Bone Miner Res"},{"key":"1475_CR21","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1210\/jc.2016-1801","volume":"101","author":"PD Miller","year":"2016","unstructured":"Miller PD, Pannacciulli N, Brown JP et al (2016) Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates. J Clin Endocrinol Metab 101:3163\u20133170","journal-title":"J Clin Endocrinol Metab"},{"key":"1475_CR22","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.3346\/jkms.2022.37.e68","volume":"37","author":"T Kang","year":"2022","unstructured":"Kang T, Park SY, Lee SH, Park JH, Suh SW (2022) Comparison of denosumab and zoledronic acid in postmenopausal women with osteoporosis: bone mineral density (BMD) and trabecular bone score (TBS). J Korean Med Sci 37:e68","journal-title":"J Korean Med Sci"},{"key":"1475_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jcsm.12411","volume":"10","author":"SSY Yeung","year":"2019","unstructured":"Yeung SSY, Reijnierse EM, Pham VK, Trappenburg MC, Lim WK, Meskers CGM, Maier AB (2019) Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 10:485\u2013500","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1475_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00198-018-04828-0","volume":"30","author":"RMY Wong","year":"2019","unstructured":"Wong RMY, Wong H, Zhang N, Chow SKH, Chau WW, Wang J, Chim YN, Leung KS, Cheung WH (2019) The relationship between sarcopenia and fragility fracture-a systematic review. Osteoporos Int 30:541\u2013553","journal-title":"Osteoporos Int"},{"key":"1475_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12877-016-0349-4","volume":"16","author":"C Beaudart","year":"2016","unstructured":"Beaudart C, McCloskey E, Bruy\u00e8re O et al (2016) Sarcopenia in daily practice: assessment and management. BMC Geriatr 16:170","journal-title":"BMC Geriatr"},{"key":"1475_CR26","doi-asserted-by":"publisher","first-page":"e2020836","DOI":"10.1001\/jamanetworkopen.2020.20836","volume":"3","author":"D Rooks","year":"2020","unstructured":"Rooks D, Swan T, Goswami B et al (2020) Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial. JAMA Netw Open 3:e2020836","journal-title":"JAMA Netw Open"},{"key":"1475_CR27","doi-asserted-by":"crossref","unstructured":"Lo JH, Yiu T, Ong MT, Lee WY. (2020) Sarcopenia: current treatments and new regenerative therapeutic approaches. J Orthop Translat 23:38\u201352","DOI":"10.1016\/j.jot.2020.04.002"},{"key":"1475_CR28","doi-asserted-by":"publisher","first-page":"155597","DOI":"10.1016\/j.metabol.2023.155597","volume":"149","author":"Y Rolland","year":"2023","unstructured":"Rolland Y, Dray C, Vellas B, Barreto PS (2023) Current and investigational medications for the treatment of sarcopenia. Metabolism 149:155597","journal-title":"Metabolism"},{"key":"1475_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.12659\/AJCR.882771","volume":"13","author":"SS Lefkowitz","year":"2012","unstructured":"Lefkowitz SS, Lefkowitz DL, Kethley J (2012) Treatment of facioscapulohumeral muscular dystrophy with denosumab. Am J Case Rep 13:66\u201368","journal-title":"Am J Case Rep"},{"key":"1475_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/DHPS.S7727","volume":"3","author":"EM Lewiecki","year":"2011","unstructured":"Lewiecki EM (2011) Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis. Drug Healthc Patient Saf 3:79\u201391","journal-title":"Drug Healthc Patient Saf"},{"key":"1475_CR31","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s00198-022-06470-3","volume":"33","author":"T Rupp","year":"2022","unstructured":"Rupp T, von Vopelius E, Strahl A, Oheim R, Barvencik F, Amling M, Rolvien T (2022) Beneficial effects of denosumab on muscle performance in patients with low BMD: a retrospective, propensity score-matched study. Osteoporos Int 33:2177\u20132184","journal-title":"Osteoporos Int"},{"key":"1475_CR32","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/jcsm.13335","volume":"14","author":"L Slade","year":"2023","unstructured":"Slade L, Bollen SE, Bass JJ, Phillips BE, Smith K, Wilkinson DJ, Szewczyk NJ, Atherton PJ, Etheridge T (2023) Bisphosphonates attenuate age-related muscle decline in Caenorhabditis elegans. J Cachexia Sarcopenia Muscle 14:2613\u20132622","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1475_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.nmd.2015.09.015","volume":"26","author":"SH Yoon","year":"2016","unstructured":"Yoon SH, Sugamori KS, Grynpas MD, Mitchell J (2016) Positive effects of bisphosphonates on bone and muscle in a mouse model of Duchenne muscular dystrophy. Neuromuscul Disord 26:73\u201384","journal-title":"Neuromuscul Disord"},{"key":"1475_CR34","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.2147\/DDDT.S328858","volume":"15","author":"CF Huang","year":"2021","unstructured":"Huang CF, Shiao MS, Mao TY (2021) Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients. Drug Des Devel Ther 15:3711\u20133715","journal-title":"Drug Des Devel Ther"},{"key":"1475_CR35","doi-asserted-by":"publisher","first-page":"951346","DOI":"10.3389\/fnut.2022.951346","volume":"9","author":"M C\u00e1\u00f1ez-R\u00edos","year":"2022","unstructured":"C\u00e1\u00f1ez-R\u00edos M, Esparza-Romero J, Gonz\u00e1lez-Arellanes R, Ram\u00edrez-Torres M, Figueroa-Pesqueira G, Urquidez-Romero R, Rangel-Peniche DB, Alem\u00e1n-Mateo H (2022) External validation of BIA equations to estimate appendicular skeletal muscle mass in older adults: importance of the bias analysis and derivation of correction factors to achieve agreement. Front Nutr 9:951346","journal-title":"Front Nutr"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-024-01475-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-024-01475-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-024-01475-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:17:07Z","timestamp":1766524627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-024-01475-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1475"],"URL":"https:\/\/doi.org\/10.1007\/s11657-024-01475-3","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was reviewed and approved by the Institutional Review Board of Yeouido St. Mary\u2019s Hospital (XC16OIMI0031S).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"17"}}